Product categories

Nuclear Medicine

PARTITION FLASK

Name:
Partition Flask

Active Principle:
Vial with mixed organic/aqueous solvents

Description:
Vial containing a mixture of solvents to carry out a chromatographic separation that allows controlling the labeled radiopharmaceutical through the use of BACMT.

PARTITION FLASK

Línea

Nuclear Medicine

Sublínea

Equipment and Accessories

PARTITION FLASK

PARTITION FLASK

Línea

Nuclear Medicine

Sublínea

Equipment and Accessories

PARTITION FLASK

Nuclear Medicine

PARTITION FLASK

Name:
Partition Flask

Active Principle:
Vial with mixed organic/aqueous solvents

Description:
Vial containing a mixture of solvents to carry out a chromatographic separation that allows controlling the labeled radiopharmaceutical through the use of BACMT.

Product categories

RELATED PRODUCTS

  • LINFOFAST

    LINFOFAST
    It is indicated for scintigraphic visualization of lymphatic vessels and lymph node stations by means of static or dynamic lymphoscintigraphy or radioisotopic lymphography. The static morphological...
    Ver más

  • BAC MT

    BAC MT
    Device for the marking and control of Kits ...
    Ver más

  • DMSA

    DMSA
    It is indicated for renal scintigraphy by means of static (planar or tomographic) and dynamic images of the kidney by scintigraphy; whether they are morphological studies of the renal cortex, function...
    Ver más

  • 131I MIBG BACON (R&D)

    131I MIBG BACON (R&D)
    It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas...
    Ver más

  • 177Lu DOTATATE (I+D)

    177Lu DOTATATE (I+D)
    It is a radiolabeled somatostatin analog indicated for: - The treatment of gastroenteropancreatic tumors positive for the somatostatin receptor. Neuroendocrine tumors (GEP-NETs), including the foregut...
    Ver más

  • FLUORIDE

    FLUORIDE
    It is indicated for the evaluation of areas of altered osteogenic activity in recurrent or metastatic primary disease of various tumors.
    Ver más

  • MIBG 131 WITHOUT CARRIER (R&D)

    MIBG 131 WITHOUT CARRIER (R&D)
    It is a radioactive therapeutic agent indicated for ...
    Ver más

  • PSMA (R+D)

    PSMA (R+D)
    It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases.
    Ver más